ADIAL PHARMACEUTICALS, INC. — 424B3 Filings
17 424B3 filings on record
This page lists all 424B3 filings submitted to the SEC by ADIAL PHARMACEUTICALS, INC. (ADIL), sorted by most recent first. Each row links to the full filing on EdgarLookup. ADIAL PHARMACEUTICALS, INC. has filed 17 424B3 documents with the SEC since 2011. To view all SEC filings by ADIAL PHARMACEUTICALS, INC., see the full filings list.
All
10-K
10-Q
10-Q/A
25-NSE
3
4
4/A
424B3
424B4
424B5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
NT 10-Q
NT 10-Q/A
POS AM
PRE 14A
PRER14A
RW
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 424B3 | PROSPECTUS | 0001213900-25-053091 | Jun 10, 2025 | — |
| 424B3 | PROSPECTUS | 0001213900-24-113730 | Dec 31, 2024 | — |
| 424B3 | PROSPECTUS | 0001213900-24-035359 | Apr 23, 2024 | — |
| 424B3 | PROSPECTUS | 0001213900-23-088508 | Nov 20, 2023 | — |
| 424B3 | PROSPECTUS | 0001213900-23-060917 | Jul 31, 2023 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-22-019420 | Apr 12, 2022 | — |
| 424B3 | PROSPECTUS | 0001213900-21-065798 | Dec 17, 2021 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-21-039604 | Jul 30, 2021 | — |
| 424B3 | PROSPECTUS | 0001213900-21-032346 | Jun 14, 2021 | — |
| 424B3 | PROSPECTUS | 0001213900-21-029793 | May 28, 2021 | — |
| 424B3 | PROSPECTUS | 0001213900-20-043054 | Dec 16, 2020 | — |
| 424B3 | PROSPECTUS | 0001213900-20-017356 | Jul 13, 2020 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-20-013336 | May 22, 2020 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-20-013332 | May 22, 2020 | — |
| 424B3 | PROSPECTUS | 0001213900-19-005565 | Apr 2, 2019 | — |
| 424B3 | PROSPECTUS SUPPLEMENT NO. 2 | 0001213900-18-015655 | Nov 14, 2018 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-18-012305 | Sep 10, 2018 | — |